non-steroidal anti-inflammatory drug

PreclinicalSmall molecule

non-steroidal anti-inflammatory drug is one of 86 small molecule programs targeting Migraine. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MigraineActive, not recruiting

Rheumatoid ArthritisActive, not recruiting

ResistanceCompleted

MigrainePreclinical

Active, not recruiting

Rheumatoid ArthritisPreclinical

Active, not recruiting

ResistancePreclinical

Completed

Competition

Competitive Landscape

181 competitors in Rheumatoid Arthritis

#DrugCompanyPhaseTrials

Actos

Takeda

Preclinical

2 2

Celexa

AbbVie

Preclinical

1 3

Voltaren

Cataflam

Plaquenil

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

2 7

Velcade

SShilpa Grover, MD, MPH

Preclinical

2 8

Vancocin

HHikma Pharmaceuticals LLC

Preclinical

1 9

Disalcid

JJoslin Diabetes Center

Preclinical

—10

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Injury1 trial

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

Completed·SSucampo Pharma Americas, LLC·Phase 2·NCT00597818·121 enrolled

Migraine1 trial

Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine

Completed· GSK logo

GSK··NCT01435941·11,249 enrolled

Resistance1 trial

Ibuprofen Supplementation After Resistance Training and Its Effects on Bone in Older Women

Completed·UUniversity of Saskatchewan·N/A·NCT01886196·90 enrolled

Rheumatoid Arthritis1 trial

Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood

Completed·CChinese Academy of Sciences·N/A·NCT01619176·10 enrolled

Adult1 trial

Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants

Completed· GSK logo

GSK·Phase 1·NCT04484337·138 enrolled

1 more indication

Long-term Follow-up1 trial

Long-term Follow-up of Lichtenstein's Operation Versus Mesh Plug Repair

Completed·UUniversity Hospital, Basel, Switzerland·N/A·NCT01637818·594 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for non-steroidal anti-inflammatory drug. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — non-steroidal anti-inflammatory drug compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for non-steroidal anti-inflammatory drug. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: GSK

non-steroidal anti-inflammatory drug

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Injury1 trial

Migraine1 trial

Resistance1 trial

Rheumatoid Arthritis1 trial

Adult1 trial

Long-term Follow-up1 trial

References

Drug Info

Quick Facts

Related News